IN2012DN04875A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN04875A IN2012DN04875A IN4875DEN2012A IN2012DN04875A IN 2012DN04875 A IN2012DN04875 A IN 2012DN04875A IN 4875DEN2012 A IN4875DEN2012 A IN 4875DEN2012A IN 2012DN04875 A IN2012DN04875 A IN 2012DN04875A
- Authority
- IN
- India
- Prior art keywords
- antigen
- stimulated
- immune response
- prx1
- compositions
- Prior art date
Links
- 239000000427 antigen Substances 0.000 abstract 5
- 102000036639 antigens Human genes 0.000 abstract 5
- 108091007433 antigens Proteins 0.000 abstract 5
- 230000028993 immune response Effects 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000004853 protein function Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/17—Monocytes; Macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
- C12Y111/01—Peroxidases (1.11.1)
- C12Y111/01015—Peroxiredoxin (1.11.1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26764709P | 2009-12-08 | 2009-12-08 | |
| PCT/US2010/059411 WO2011071988A1 (en) | 2009-12-08 | 2010-12-08 | Methods and compositions using peroxiredoxin 1 (prx1) as an adjuvant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN04875A true IN2012DN04875A (OSRAM) | 2015-09-25 |
Family
ID=44145890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4875DEN2012 IN2012DN04875A (OSRAM) | 2009-12-08 | 2010-12-08 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9050291B2 (OSRAM) |
| EP (1) | EP2509623B1 (OSRAM) |
| KR (1) | KR20130028044A (OSRAM) |
| CN (1) | CN102834110B (OSRAM) |
| CA (1) | CA2782132A1 (OSRAM) |
| IN (1) | IN2012DN04875A (OSRAM) |
| WO (1) | WO2011071988A1 (OSRAM) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103468652A (zh) * | 2013-07-15 | 2013-12-25 | 中国科学院海洋研究所 | 一种纯化fitc标记的虾白斑综合症病毒（wssv）的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9612214D0 (en) * | 1996-06-11 | 1996-08-14 | Mallinckrodt Veterinary Inc | Vaccine |
| ES2355588T3 (es) * | 1997-03-14 | 2011-03-29 | The Children's Hospital Of Philadelphia | Composiciones para uso en terapia génica para el tratamiento de hemofilia. |
| IL125608A0 (en) * | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| US6753314B1 (en) * | 1999-04-01 | 2004-06-22 | Curagen Corporation | Protein-protein complexes and methods of using same |
| US20020168353A1 (en) * | 2001-03-23 | 2002-11-14 | Lynn Ralf Geiben | Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof |
| US20090291087A1 (en) | 2002-03-21 | 2009-11-26 | University Of Florida Research Foundation, Inc. | Modulating angiogenesis |
| US20030199464A1 (en) | 2002-04-23 | 2003-10-23 | Silviu Itescu | Regeneration of endogenous myocardial tissue by induction of neovascularization |
| US8153410B2 (en) * | 2003-07-07 | 2012-04-10 | Fox Chase Cancer Center | Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules |
| JP2009525048A (ja) * | 2006-02-01 | 2009-07-09 | ザ ジョンズ ホプキンス ユニバーシティー | 腫瘍性障害または感染症に対する免疫学的予防法または免疫療法のためのポリペプチド−核酸複合体 |
| WO2009059281A1 (en) * | 2007-11-02 | 2009-05-07 | Health Research Inc. | Compositions and methods for using ca9 protein to stimulate an immune response |
-
2010
- 2010-12-08 IN IN4875DEN2012 patent/IN2012DN04875A/en unknown
- 2010-12-08 CN CN201080060971.5A patent/CN102834110B/zh not_active Expired - Fee Related
- 2010-12-08 EP EP10836594.1A patent/EP2509623B1/en not_active Not-in-force
- 2010-12-08 KR KR1020127016307A patent/KR20130028044A/ko not_active Withdrawn
- 2010-12-08 US US12/963,008 patent/US9050291B2/en not_active Expired - Fee Related
- 2010-12-08 WO PCT/US2010/059411 patent/WO2011071988A1/en not_active Ceased
- 2010-12-08 CA CA2782132A patent/CA2782132A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN102834110A (zh) | 2012-12-19 |
| EP2509623A4 (en) | 2013-06-26 |
| WO2011071988A1 (en) | 2011-06-16 |
| US9050291B2 (en) | 2015-06-09 |
| EP2509623A1 (en) | 2012-10-17 |
| CN102834110B (zh) | 2015-01-14 |
| CA2782132A1 (en) | 2011-06-16 |
| US20110177129A1 (en) | 2011-07-21 |
| EP2509623B1 (en) | 2015-03-25 |
| KR20130028044A (ko) | 2013-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2013054199A3 (en) | Cmv antigens and uses thereof | |
| WO2008116078A8 (en) | Stimulation of an immune response by cationic lipids | |
| SMT201700182T1 (it) | Composizioni di composti modificanti la risposta immunitaria lipidati, formulazioni e metodi | |
| SMT201800444T1 (it) | Metodi e composizioni per indurre una risposta immunitaria contro egfrviii | |
| ZA201307394B (en) | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses | |
| WO2012027365A3 (en) | Targeted multi-epitope dosage forms for induction of an immune response to antigens | |
| EA201391597A1 (ru) | Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки | |
| EA201490381A1 (ru) | Синтетические наноносители, которые стимулируют формирование гуморального иммунного ответа и иммунного ответа, опосредованного цитотоксическими т-лимфоцитами (ctl) | |
| PH12014501835A1 (en) | Novel adjuvant compositions | |
| AU2015296298A8 (en) | Flagellin-based agents and uses including effective vaccination | |
| WO2012125551A8 (en) | Listeria-based adjuvants | |
| MX338980B (es) | Metodos de tratamiento utilizando inhibidores de tlr7 y/o tlr9. | |
| WO2009026574A3 (en) | Immunogenic compositions and uses thereof | |
| MX346500B (es) | Metodos y composiciones para inmunoterapia para enfermedad neural. | |
| WO2012109238A3 (en) | Methods for increasing immune responses using agents that directly bind to and activate ire-1 | |
| WO2009134429A3 (en) | Methods and compositions for modulating immunological tolerance | |
| HK1243631A1 (zh) | 用於提高过继细胞免疫疗法效力的组合物和方法 | |
| SG10201900041VA (en) | Meningococcus vaccines | |
| WO2013188627A3 (en) | Cationic lipid vaccine compositions and methods of use | |
| ZA201003964B (en) | Compositions for and methods of enhancing the immune response to antigens | |
| IN2014CN03454A (OSRAM) | ||
| EP3908315A4 (en) | COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE TO VACCINATION AND ENHANCING VACCINE PRODUCTION | |
| IN2014CN00547A (OSRAM) | ||
| WO2012075104A3 (en) | Novel non-primate hepacivirus | |
| MX2012002829A (es) | Producción de una respuesta inmune para disminuir el riesgo de contagio por brucelosis. |